These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24304314)

  • 1. Using mass spectrometry-based peptidomics to understand the brain and disorders such as Parkinson's disease and schizophrenia.
    Cafe-Mendes CC; Ferro ES; Britto LR; Martins-de-Souza D
    Curr Top Med Chem; 2014; 14(3):369-81. PubMed ID: 24304314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of mouse brain peptides using mass spectrometry-based peptidomics: implications for novel functions ranging from non-classical neuropeptides to microproteins.
    Fricker LD
    Mol Biosyst; 2010 Aug; 6(8):1355-65. PubMed ID: 20428524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptidomic analysis of the anterior temporal lobe and corpus callosum from schizophrenia patients.
    Café-Mendes CC; Ferro ES; Torrão AS; Crunfli F; Rioli V; Schmitt A; Falkai P; Britto LR; Turck CW; Martins-de-Souza D
    J Proteomics; 2017 Jan; 151():97-105. PubMed ID: 27321914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Peptidome Comes of Age: Mass Spectrometry-Based Characterization of the Circulating Cancer Peptidome.
    Greening DW; Kapp EA; Simpson RJ
    Enzymes; 2017; 42():27-64. PubMed ID: 29054270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometry: A platform for biomarker discovery and validation for Alzheimer's and Parkinson's diseases.
    Cilento EM; Jin L; Stewart T; Shi M; Sheng L; Zhang J
    J Neurochem; 2019 Nov; 151(4):397-416. PubMed ID: 30474862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptidomics of the zebrafish Danio rerio: In search for neuropeptides.
    Van Camp KA; Baggerman G; Blust R; Husson SJ
    J Proteomics; 2017 Jan; 150():290-296. PubMed ID: 27705817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptidomics as a tool for characterizing bioactive milk peptides.
    Giacometti J; Buretić-Tomljanović A
    Food Chem; 2017 Sep; 230():91-98. PubMed ID: 28407976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemopressins and other hemoglobin-derived peptides in mouse brain: comparison between brain, blood, and heart peptidome and regulation in Cpefat/fat mice.
    Gelman JS; Sironi J; Castro LM; Ferro ES; Fricker LD
    J Neurochem; 2010 May; 113(4):871-80. PubMed ID: 20202081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crosstalk within GPCR heteromers in schizophrenia and Parkinson's disease: physical or just functional?
    Guixa-Gonzalez R; Bruno A; Marti-Solano M; Selent J
    Curr Med Chem; 2012; 19(8):1119-34. PubMed ID: 22300049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomics in Parkinson's disease: An unbiased approach towards peripheral biomarkers and new therapies.
    Alberio T; Fasano M
    J Biotechnol; 2011 Dec; 156(4):325-37. PubMed ID: 21925549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's and Parkinson's diseases: an environmental proteomic point of view.
    Demartini DR; Schilling LP; da Costa JC; Carlini CR
    J Proteomics; 2014 Jun; 104():24-36. PubMed ID: 24751585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptidomics of Zebrafish Brain in a 6-OHDA-Induced Neurodegeneration Model.
    Fiametti LO; de Mello FR; de Castro LM
    Methods Mol Biol; 2024; 2758():307-317. PubMed ID: 38549021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different approaches, one target: understanding cellular mechanisms of Parkinson's and Alzheimer's diseases.
    Torrão AS; Café-Mendes CC; Real CC; Hernandes MS; Ferreira AF; Santos TO; Chaves-Kirsten GP; Mazucanti CH; Ferro ES; Scavone C; Britto LR
    Braz J Psychiatry; 2012 Oct; 34 Suppl 2():S194-205. PubMed ID: 23429847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human tear proteomics and peptidomics in ophthalmology: Toward the translation of proteomic biomarkers into clinical practice.
    Azkargorta M; Soria J; Acera A; Iloro I; Elortza F
    J Proteomics; 2017 Jan; 150():359-367. PubMed ID: 27184738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptidomics: identification and quantification of endogenous peptides in neuroendocrine tissues.
    Fricker LD; Lim J; Pan H; Che FY
    Mass Spectrom Rev; 2006; 25(2):327-44. PubMed ID: 16404746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Origins, Technological Advancement, and Applications of Peptidomics.
    Schrader M
    Methods Mol Biol; 2024; 2758():3-47. PubMed ID: 38549006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Origins, Technological Development, and Applications of Peptidomics.
    Schrader M
    Methods Mol Biol; 2018; 1719():3-39. PubMed ID: 29476501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emerging role of the peptidome in biomarker discovery and degradome profiling.
    Lai ZW; Petrera A; Schilling O
    Biol Chem; 2015 Mar; 396(3):185-92. PubMed ID: 25229414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Optimized Informatics Pipeline for Mass Spectrometry-Based Peptidomics.
    Wu C; Monroe ME; Xu Z; Slysz GW; Payne SH; Rodland KD; Liu T; Smith RD
    J Am Soc Mass Spectrom; 2015 Dec; 26(12):2002-8. PubMed ID: 26015166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomics of the corpus callosum unravel pivotal players in the dysfunction of cell signaling, structure, and myelination in schizophrenia brains.
    Saia-Cereda VM; Cassoli JS; Schmitt A; Falkai P; Nascimento JM; Martins-de-Souza D
    Eur Arch Psychiatry Clin Neurosci; 2015 Oct; 265(7):601-12. PubMed ID: 26232077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.